Status:
ACTIVE_NOT_RECRUITING
Examining the Feasibility of Prolonged Ketone Concentrate Supplement Drink Consumption in Adults With Type 2 Diabetes
Lead Sponsor:
University of British Columbia
Conditions:
Diabetes Mellitus, Type 2
Hyperglycemia
Eligibility:
All Genders
30-69 years
Phase:
NA
Brief Summary
Brief Summary: Ketones are a source of energy and signaling molecule that are produced by the body when not consuming any food or consistently eating a low-carbohydrate "keto" diet. Blood ketones can...
Eligibility Criteria
Inclusion
- diagnosed with type 2 diabetes by a physician at least 1 year prior
- stable use of glucose-lowering medications for at least three months
- must be able to read and understand English in order to complete the study questionnaires
Exclusion
- competitively trained endurance athlete
- actively attempting to gain or lose weight
- having a history of mental illness or existing neurological disease
- having a history of cardiovascular events in the last two years, hypoglycemia, irritable bowel syndrome, or inflammatory bowel disease
- are currently taking SGLT2 inhibitors or insulin
- are using more than 2 classes of glucose-lowering medication
- currently following a ketogenic diet or regularly taking ketone supplements
- unable to commit to a 90-day trial
- being unable to follow remote guidance by internet or smartphone
- currently taking natural or over-the-counter supplements specifically designed to lower blood glucose (e.g., berberine, bitter melon)
Key Trial Info
Start Date :
June 26 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05983562
Start Date
June 26 2023
End Date
March 1 2024
Last Update
February 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of British Columbia Okanagan
Kelowna, British Columbia, Canada, V1V 1V7